You are here

Article info

Article menu
XML
GI cancer
Original article
Mesalazine and thymoquinone attenuate intestinal tumour development in Msh2loxP/loxP Villin-Cre mice

Authors

  1. Correspondence to Professor Christoph Gasche, Division of Gastroenterology and Hepatology, Department of Medicine 3, Christian Doppler Laboratory for Molecular Cancer Chemoprevention, Medical University of Vienna, Währinger Gürtel 18-20, Vienna 1090, Austria; christoph.gasche{at}meduniwien.ac.at
View Full Text

Citation

Kortüm B, Campregher C, Lang M, et al
Mesalazine and thymoquinone attenuate intestinal tumour development in Msh2loxP/loxP Villin-Cre mice
Gut 2015;64:1905-1912.

Publication history

  • Received May 16, 2014
  • Revised September 26, 2014
  • Accepted October 14, 2014
  • First published November 26, 2014.
Online issue publication 
October 26, 2017

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/